Recall archive / FDA drug enforcement
Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Sh... — FDA record D-0583-2024
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Jun 7, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106 USA, NDC 55111-730-01.
- Reason
- Presence of foreign substance.
- Classification
- Class II
- Recalling firm
- Dr. Reddy's Laboratories, Inc.
- Quantity
- 20,520 units
- Agency-reported status
- Terminated
- Source record identifier
- D-0583-2024
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | L2300594 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
IL, MS, OH
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Jul 10, 2024
- Recall initiation date
- Jun 7, 2024
- Center classification date
- Jul 3, 2024
- Termination date
- Dec 22, 2025
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.